|
[1]
|
Grasso, G., Alafaci, C. and Macdonald, R.L. (2017) Management of Aneurysmal Subarachnoid Hemorrhage: State of the Art and Future Perspectives. Surgical Neurology International, 8, 11. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Tewari, M., Aggarwal, A., Mathuriya, S. and Gupta, V. (2015) The Outcome after Aneurysmal Sub Arachnoid Hemorrhage: A Study of Various Factors. Annals of Neurosciences, 22, 78-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kabadi, S.V., Stoica, B.A., Zimmer, D.B., et al. (2015) S100B Inhibition Reduces Behavioral and Pathologic Changes in Experimental Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabolism, 35, 2010-2020. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
王艳萍, 华颖, 徐晓华, 王健彪. miRNA-146a和Toll样受体2对幼鼠细菌性脑膜炎的影响[J]. 重庆医学, 2018, 47(10): 1398-1400.
|
|
[5]
|
Jung, C.S., Lange, B., Zimmermann, M. and Seifert, V. (2013) CSF and Serum Biomarkers Focusing on Cerebral Vasospasm and Ischemia after Subarachnoid Hemorrhage. Stroke Research and Treatment, 2013, Article ID: 560305. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Abboud, T., Mende, K.C., Jung, R., et al. (2017) Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. World Neurosurgery, 108, 669-675. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Kellermann, I., Kleindienst, A., Hore, N., Buchfelder, M. and Brandner, S. (2016) Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage. Clinical Neurology and Neurosurgery, 145, 79-83. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Burke, J.E. and Dennis, E.A. (2009) Phospholipase A2 Biochemistry. Cardiovascular Drugs and Therapy, 23, 49-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Tellis, C.C. and Tselepis, A.D. (2014) Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A₂ (Lp-PLA₂) Bound to LDL and HDL. Current Pharmaceutical Design, 20, 6256-6269. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Xu, R.X., Zhang, Y., Li, X.L., et al. (2015) Relationship between Plasma Phospholipase A2 Concentrations and Lipoprotein Subfractions in Patients with Stable Coronary Artery Disease. Clinica Chimica Acta, 446, 195-200. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Maiolino, G., Pedon, L., Cesari, M., et al. (2012) Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients. PLoS ONE, 7, e48171. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cai, A., Li, G., Chen, J., Li, X., Li, L. and Zhou, Y. (2015) Increased Serum Level of Lp-PLA2 Is Independently Associated with the Severity of Coronary Artery Diseases: A Cross-Sectional Study of Chinese Population. BMC Cardiovascular Disorders, 15, Article No. 14. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Silva, I.T., Mello, A.P. and Damasceno, N.R. (2011) Antioxidant and Inflammatory Aspects of Lipoprotein-Associated Phospholipase A₂ (Lp-PLA₂): A Review. Lipids in Health and Disease, 10, 170. [Google Scholar] [CrossRef]
|
|
[14]
|
Wang, Y., Hu, S., Ren, L., et al. (2019) Lp-PLA(2) as a Risk Factor of Early Neurological Deterioration in Acute Ischemic Stroke with TOAST Type of Large Arterial Atherosclerosis. Neurological Research, 41, 1-8. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
李丽娟. 同型半胱氨酸水平与脑梗死患者严重程度及神经缺损功能的关系研究[J]. 实验与检验医学, 2018, 36(6): 925-926+973.
|
|
[16]
|
Chung, H., Kwon, H.M., Kim, J.Y., et al. (2014) Lipoprotein-Associated Phospholipase A₂ Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome. Yonsei Medical Journal, 55, 1507-1515. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Yang, F., Ma, L., Zhang, L., et al. (2019) Association between Serum Lipoprotein-Associated Phospholipase A2, Ischemic Modified Albumin and Acute Coronary Syndrome: A Cross-Sectional Study. Heart Vessels, 34, 1608-1614. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
《脂蛋白相关的磷脂酶A2临床应用中国专家建议》发布[J]. 中国医药导刊, 2015, 17(11): 1154.
|
|
[19]
|
曹雄彬, 宫丽, 匡良洪, 等. 脑出血患者微创抽吸引流术前后白细胞介素-6、白细胞介素-10和磷脂酶A2水平变化及临床意义[J]. 微循环学杂志, 2016, 26(2): 46-48+52.
|
|
[20]
|
Rosso, C., Rosenbaum, D., Pires, C., et al. (2014) Lipoprotein-Associated Phospholipase A2 during the Hyperacute Stage of Ischemic and Hemorrhagic Strokes. Journal of Stroke and Cerebrovascular Diseases, 23, e277-e282. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
孙锴, 王焱, 王大同, 杨龙, 程言博. Lp-PLA2、Hcy表达水平与动脉瘤性蛛网膜下腔出血预后的关系[J]. 热带医学杂志, 2019, 19(12): 1519-1523.
|
|
[22]
|
吴凤娇, 母迷迷, 何晶, 马华, 郭术俊, 宋传旺. 胰岛素样生长因子1对小鼠肺泡上皮细胞吞噬功能和白细胞介素10产生的影响[J]. 上海交通大学学报(医学版), 2019, 39(3): 253-257.
|
|
[23]
|
Rotwein, P. (2017) Diversification of the Insulin-Like Growth Factor 1 Gene in Mammals. PLoS ONE, 12, e0189642. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Gligorijevic, N., Robajac, D. and Nedic, O. (2019) Enhanced Platelet Sensitivity to IGF-1 in Patients with Type 2 Diabetes Mellitus. Biochemistry (Mosc), 84, 1213-1219. [Google Scholar] [CrossRef]
|
|
[25]
|
van Bunderen, C.C., van Nieuwpoort, I.C., van Schoor, N.M., Deeg, D.J., Lips, P. and Drent, M.L. (2010) The Association of Serum Insulin-Like Growth Factor-I with Mortality, Cardiovascular Disease, and Cancer in the Elderly: A Population-Based Study. The Journal of Clinical Endocrinology & Metabolism, 95, 4616-4624. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Zemva, J. and Schubert, M. (2011) Central Insulin and Insulin-Like Growth Factor-1 Signaling: Implications for Diabetes Associated Dementia. Current Diabetes Reviews, 7, 356-366. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Yeap, B.B., Paul Chubb, S.A., Lopez, D., Ho, K.K., Hankey, G.J. and Flicker, L. (2013) Associations of Insulin-Like Growth Factor-I and Its Binding Proteins and Testosterone with Frailty in Older Men. Clinical Endocrinology, 78, 752-759. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Duron, E., Funalot, B., Brunel, N., et al. (2012) Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer’s Disease. The Journal of Clinical Endocrinology & Metabolism, 97, 4673-4681. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Godau, J., Herfurth, M., Kattner, B., Gasser, T. and Berg, D. (2010) Increased Serum Insulin-Like Growth Factor 1 in Early Idiopathic Parkinson’s Disease. Journal of Neurology, Neurosurgery & Psychiatry, 81, 536-538. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tölli, A., Höybye, C., Bellander, B.M. and Borg, J. (2019) Impact of Pituitary Dysfunction on Cognitive and Global Outcome after Traumatic Brain Injury and Aneurysmal Subarachnoid Haemorrhage. Journal of Rehabilitation Medicine, 51, 264-272. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Jonasdottir, A.D., Sigurjonsson, P., Olafsson, I.H., Karason, S., Sigthorsson, G. and Sigurjonsdottir, H.A. (2018) Hypopituitarism 3 and 12 Months after Traumatic Brain Injury and Subarachnoid Haemorrhage. Brain Injury, 32, 310-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Goto, Y., Oshino, S., Nishino, A., et al. (2016) Pituitary Dysfunction after Aneurysmal Subarachnoid Hemorrhage in Japanese Patients. Journal of Clinical Neuroscience, 34, 198-201. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Can, A., Gross, B.A., Smith, T.R., et al. (2016) Pituitary Dysfunction after Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. Neurosurgery, 79, 253-264. [Google Scholar] [CrossRef]
|
|
[34]
|
Bacigaluppi, S., Robba, C. and Bragazzi, N.L. (2021) Pituitary Dysfunction after Aneurysmal Subarachnoidal Hemorrhage. In: Handbook of Clinical Neurology, Vol. 181, Elsevier, Amsterdam, 41-49. [Google Scholar] [CrossRef]
|
|
[35]
|
Giritharan, S., Cox, J., Heal, C.J., Hughes, D., Gnanalingham, K. and Kearney, T. (2017) The Prevalence of Growth Hormone Deficiency in Survivors of Subarachnoid Haemorrhage: Results from a Large Single Centre Study. Pituitary, 20, 624-634. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Nowrangi, D.S., McBride, D., Manaenko, A., Dixon, B., Tang, J. and Zhang, J.H. (2019) rhIGF-1 Reduces the Permeability of the Blood-Brain Barrier Following Intracerebral Hemorrhage in Mice. Experimental Neurology, 312, 72-81. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Tizon, B., Sahoo, S., Yu, H., et al. (2010) Induction of Autophagy by Cystatin C: A Mechanism That Protects Murine Primary Cortical Neurons and Neuronal Cell Lines. PLoS ONE, 5, e9819. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Liu, Y., Cai, H., Wang, Z., et al. (2013) Induction of Autophagy by Cystatin C: A Potential Mechanism for Prevention of Cerebral Vasospasm after Experimental Subarachnoid Hemorrhage. European Journal of Medical Research, 18, 21. [Google Scholar] [CrossRef]
|
|
[39]
|
王雅楠, 王晓华, 吴洁, 徐亚男, 潘濛, 花放. 低水平的血清胱抑素C与脑动脉瘤关系密切[J]. 神经损伤与功能重建, 2017, 12(3): 206-208.
|
|
[40]
|
Zhang, D., Wu, W., Yan, H., et al. (2016) Upregulation of HMGB1 in Wall of Ruptured and Unruptured Human Cerebral Aneurysms: Preliminary Results. Neurological Sciences, 37, 219-226. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Tang, D., Kang, R., Zeh, H.J. and Lotze, M.T. (2011) High-Mobility Group Box 1, Oxidative Stress, and Disease. Antioxidants & Redox Signaling, 14, 1315-1335. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Venereau, E., De Leo, F., Mezzapelle, R., Careccia, G., Musco, G. and Bianchi, M.E. (2016) HMGB1 as Biomarker and Drug Target. Pharmacological Research, 111, 534-544. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Chen, Y., Li, G., Liu, Y., Werth, V.P., Williams, K.J. and Liu, M.L. (2016) Translocation of Endogenous Danger Signal HMGB1 from Nucleus to Membrane Microvesicles in Macrophages. Journal of Cellular Physiology, 231, 2319-2326. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Sun, Q., Wu, W., Hu, Y.C., et al. (2014) Early Release of High-Mobility Group Box 1 (HMGB1) from Neurons in Experimental Subarachnoid Hemorrhage in Vivo and in Vitro. Journal of Neuroinflammation, 11, 106. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
King, M.D., Laird, M.D., Ramesh, S.S., et al. (2010) Elucidating Novel Mechanisms of Brain Injury Following Subarachnoid Hemorrhage: An Emerging role for Neuroproteomics. Neurosurgical Focus, 28, E10. [Google Scholar] [CrossRef]
|
|
[46]
|
Nakahara, T., Tsuruta, R., Kaneko, T., et al. (2009) High-Mobility Group Box 1 Protein in CSF of Patients with Subarachnoid Hemorrhage. Neurocritical Care, 11, 362-368. [Google Scholar] [CrossRef] [PubMed]
|